Frontiers in Immunology (Jul 2022)

Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer

  • Qian Zou,
  • Xue Lei,
  • Aijing Xu,
  • Ziqi Li,
  • Qinglian He,
  • Xiujuan Huang,
  • Xiujuan Huang,
  • Guangxian Xu,
  • Faqing Tian,
  • Faqing Tian,
  • Yuanlin Ding,
  • Wei Zhu

DOI
https://doi.org/10.3389/fimmu.2022.724139
Journal volume & issue
Vol. 13

Abstract

Read online

Plenty of factors affect the oncogenesis and progression of colorectal cancer in the tumor microenvironment, including various immune cells, stromal cells, cytokines, and other factors. Chemokine is a member of the cytokine superfamily. It is an indispensable component in the tumor microenvironment. Chemokines play an antitumor or pro-tumor role by recruitment or polarization of recruiting immune cells. Meanwhile, chemokines, as signal molecules, participate in the formation of a cross talk among signaling pathways and non-coding RNAs, which may be involved in promoting tumor progression. In addition, they also function in immune escape. Chemokines are related to drug resistance of tumor cells and may even provide reference for the diagnosis, therapy, and prognosis of patients with colorectal cancer.

Keywords